# Integrating Genomic Pathway and Clinical Modeling for Mortality Prediction in Breast Cancer

**Predicting breast cancer mortality risk by combining clinical variables with transcriptome-derived pathway activity for more interpretable and biologically grounded prognostic models.**

---

## 🚀 Project Overview

Breast cancer exhibits extensive molecular and clinical heterogeneity, which complicates prognosis and treatment planning. While clinical models (e.g., age, tumor stage, treatment history) provide a baseline risk estimate, they often fail to capture underlying molecular mechanisms that drive cancer aggressiveness.  

This project explores an **integrative machine-learning framework** that combines **clinical metadata** with **pathway-level genomic features** derived from gene expression data to predict mortality risk in breast cancer patients. By merging clinical and molecular data, our goal is to build prediction models that are not only **more accurate**, but also **biologically interpretable** — linking pathway dysregulation to patient outcomes.

---

## 📄 What’s in this Repository
- Final_DS_pipeline.ipynb # Main Jupyter notebook containing the full analysis pipeline
- README.md # This documentation file

---

## 🛠 Main Analysis Workflow (in `Final_DS_pipeline.ipynb`)

1. **Data ingestion & preprocessing**  
   - Load clinical metadata and gene expression data  
   - Clean and preprocess data (filtering, normalization, missing-value handling)  

2. **Pathway-level feature extraction**  
   - Transform gene-level expression data into pathway-activity scores using [pathway-enrichment / gene set scoring] methods  
   - Generate a molecular profile for each patient based on pathway activity  

3. **Data integration**  
   - Merge pathway-activity features with clinical metadata to create a combined feature matrix  

4. **Model training and evaluation**  
   - Train machine-learning models (e.g., logistic regression, random forest, etc.) for binary mortality prediction  
   - Use cross-validation or train/test split for performance evaluation  

5. **Interpretation & feature importance**  
   - Interpret model predictions using feature-importance metrics or SHAP (Shapley Additive exPlanations) values  
   - Identify which pathways (and clinical features) contribute most to mortality risk  

6. **Visualization & reporting**  
   - Generate summary plots, feature importance graphs, ROC curves, etc.  
   - Document findings and key insights  

---

## 🎯 Why This Matters

- Integrative models like this support **precision oncology** by combining clinical and molecular data.  
- Pathway-level features help reveal **biological mechanisms** underlying poor prognosis (e.g., dysregulated signaling pathways) rather than relying solely on clinical covariates.  
- The approach enhances **interpretability** and potentially **clinical relevance**, helping guide risk stratification, treatment decisions, or hypothesis generation for further research.  

---

## 📥 How to Run the Analysis

1. Clone the repository:  
    ```bash
    git clone https://github.com/haiderabbas678/Integrating-Genomic-Pathway-and-Clinical-Modeling-for-Mortality-Prediction-in-Breast-Cancer.git
    cd Integrating-Genomic-Pathway-and-Clinical-Modeling-for-Mortality-Prediction-in-Breast-Cancer
    ```

2. (Optional but recommended) Create a virtual environment and install dependencies:  
    ```bash
    python -m venv venv
    source venv/bin/activate      # Linux / macOS  
    # or venv\Scripts\activate     # Windows  
    pip install -r requirements.txt
    ```  
   *(If you don’t have a `requirements.txt`, manually install the required packages used in the notebook.)*

3. Launch the notebook:  
    ```bash
    jupyter notebook Final_DS_pipeline.ipynb
    ```  
   or, if you prefer, run it with `jupyter lab`.

4. Follow the notebook — each section is annotated and can be executed step-by-step to reproduce the analysis and figures.

---

## 📚 Background & Related Work

This project is inspired by prior research on integrating genomic and clinical data for outcome prediction. Similar studies have shown that pathway-informed models can outperform clinical-only models and offer greater biological interpretability. :contentReference[oaicite:0]{index=0}  

---


## 📝 License

This project is provided under the [MIT License](LICENSE), or see licensing information in the repository.  

---



